Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
conjugated linoleic acid (1 trial)
thioctic acid (1 trial)
tranexamic acid (cyklokapron) (1 trial)
allogeneic stem cells (1 trial)
atezolizumab (Tecentriq) (1 trial)
bevacizumab (avastin) (1 trial)
edoxaban (savaysa) (1 trial)
Atrial Fibrillation (Phase 2)
Cerebral Infarction (Phase 2)
Diabetic Neuropathies (Phase 4)
Ischemia (Phase 2)
Pancreatitis (Phase 2)
Stroke (Phase 2)
Trials (5 total)
Trial APIs (7 total)